Evaluation of SLC11A1 as an inflammatory bowel disease candidate gene

BMC Medical Genetics

Volumn 6, Issue , 2005, Pages

  Crawford, Nigel P S ^a   Eichenberger, Maurice R ^a   Colliver, Daniel W ^a   Lewis, Robert K ^a   Cobbs, Gary A ^b   Petras, Robert E ^c   Galandiuk, Susan ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c Ameripath Institute of Gastrointestinal Pathology and Digestive Care   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MEMBRANE PROTEIN; PROTEIN SLC11A1; UNCLASSIFIED DRUG; CATION TRANSPORT PROTEIN; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; NATURAL RESISTANCE-ASSOCIATED MACROPHAGE PROTEIN 1;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CAUCASIAN; CHILD; CONTROLLED STUDY; ENTERITIS; FEMALE; GEL ELECTROPHORESIS; GENE AMPLIFICATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; SHORT TANDEM REPEAT; CASE CONTROL STUDY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CATION TRANSPORT PROTEINS; CHILD; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED;

EID: 26444548696     PISSN: 14712350     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-6-10     Document Type: Article

References (15)

1. Podolsky DK: Inflammatory bowel disease. N Engl J Med 1991, 325:928-937.
2. Watts DA, Satsangi J: The genetic jigsaw of inflammatory bowel disease. Gut 2002, 50(Suppl 3):III31-III36.
3. Blackwell JM, Searle S, Mohamed H, White JK: Divalent cation transport and susceptibility to infectious and autoimmune disease: continuation of the Ity/Lsh/Bcg/Nramp1/SLC11A1 gene story. Immunol Lett 2003, 85:197-203.
4. Bellamy R, Ruwende C, Corrah T, McAdam KP, Whittle HC, Hill AV: Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med 1998, 338:640-644.
5. Hofmeister A, Neibergs HL, Pokorny RM, Galandiuk S: The natural resistance-associated macrophage protein gene is associated with Crohn's disease. Surgery 1997, 122:173-178.
6. Kojima Y, Kinouchi Y, Takahashi S, Negoro K, Hiwatashi N, Shimosegawa T: Inflammatory bowel disease is associated with a novel promoter polymorphism of natural resistance-associated macrophage protein 1 (NRAMP1) gene. Tissue Antigens 2001, 58:379-384.
7. Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, Jewell DP, Rachmilewitz D, Sachar DB, Sandborn WJ, Sutherland LR: A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000, 6:8-15.
8. Storey JD, Tibshirani R: Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 2003, 100:9440-9445.
9. Fisher RA: Combining independent tests of significance. American Statistician 1948, 2:30.
10. The John Storey Q-Value Method [http://genomine.org/qvalue]
11. Martin ER, Monks SA, Warren LL, Kaplan NL: A test for linkage and association in general pedigrees: the pedigree disequilibrium test. Am J Hum Genet 2000, 67:146-154.
12. Martin ER, Bass MP, Kaplan NL: Correcting for a potential bias in the pedigree disequilibrium test. Am J Hum Genet 2001, 68:1065-1067.
13. Clayton D: A generalization of the transmission/disequilibrium test for uncertain- haplotype transmission. Am J Hum Genet 1999, 65:1170-1177.
14. Searle S, Blackwell JM: Evidence for a functional repeat polymorphism in the promoter of the human NRAMP1 gene that correlates with autoimmune versus infectious disease susceptibility. J Med Genet 1999, 36:295-299.
15. Lang T, Prina E, Sibthorpe D, Blackwell JM: NRAMP1 transfection transfers Ity/Lsh/Bcg-related pleiotropic effects on macrophage activation: influence on antigen processing and presentation. Infect Immun 1997, 65:380-386.